Wouter Scheper

Wouter Scheper

Company: Netherlands Cancer Institute

Job title: Senior Postdoctoral Fellow


Identification Of Patient-Specific T Cell Neoantigens Through Hla-Agnostic Genetic Screens 11:45 am

• Identification of the T cell-recognized neoantigens in individual cancer patients is complicated by their patient-specific nature. • We have developed the first genetic neoantigen discovery platform that allows identification of both CD4+ and CD8+ T cell-recognized neoantigens with high sensitivity and across complete HLA genotypes. • This technology should facilitate the development of personalized…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.